|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.330 SEK | -5.34% |
|
-1.42% | -38.30% |
| 07-07 | Vivesto chairman Peter Zonabend increases his shareholding | FW |
| 07-01 | Vivesto Completes Enrollment in Cat Study of Paccal Vet | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 10.11M | - | - | - | - | - |
| 1,043B | |||||
| 602B | |||||
| 449B | |||||
| 327B | |||||
| 279B |
- Stock Market
- Stocks
- VIVE Stock
- Charts Vivesto AB
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
